Summary
A total of 62 patients with metastatic or locally advanced non-small-cell lung cancer were entered in a phase II study of ACNU. Initially, the drug was given i. v. at a dose of 100 mg/m2 every 6 weeks, but due to observed haematological side effects in chemotherapy-pretreated patients, the dose was lowered in this group to 75 mg/m2. We observed one complete response in a subject exhibiting multiple lung metastases and a partial response in two patients, one showing brain metastases and one who experienced local disease recurrence. The toxicity of ACNU mainly consisted of bone marrow suppression especially thrombocytopenia, with one toxic death occurring due to intracerebral haemorrhage. We concluded that at this dose and on this schedule, ACNU has limited activity in non-small-cell lung cancer.
References
Arakawa M, Shimizu F, Okada N (1974) Effect of 1-(4-amino-2-methylpyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosurea hydrochloride on leukemia L-1210. Gann 65: 191
Cooperative Study Group (1976) Phase I study of ACNU. Jpn J Clin Oncol 6: 55–62
Saijo N, Niitani H (1980) Experimental and clinical effect of ACNU in Japan, with emphasis on small-cell carcinoma of the lung. Cancer Chemother Pharmacol 4: 165–171
Sasaki Y, Saijo N, Shimuzu E (1985) Phase II study of ACNU for non-small-cell lung cancer. Eur J Cancer Clin Oncol 21: 1557–1559
Shimizu F, Arakawa M (1978) Antitumor activity of ACNU in a variety of experimental tumors. Gann 69: 545–548
Sorensen JB, Clerici M, Hansen HH (1988) Review. Single-agent chemotherapy for advanced adenocarcinoma of the lung. Cancer Chemother Pharmacol 21: 89–102
WHO (1979) Handbook for reporting results of cancer treatment. Offset Publication 45. WHO, Geneva
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Planting, A.S.T., Ardizzoni, A., Estapé, J. et al. Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872. Cancer Chemother. Pharmacol. 28, 145–146 (1991). https://doi.org/10.1007/BF00689706
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00689706